S&P 500
(0.91%) 5 064.20 points
Dow Jones
(0.85%) 38 226 points
Nasdaq
(1.51%) 15 841 points
Oil
(0.30%) $79.19
Gas
(0.15%) $2.04
Gold
(0.11%) $2 312.20
Silver
(0.26%) $26.90
Platinum
(0.05%) $963.10
USD/EUR
(-0.02%) $0.932
USD/NOK
(-0.11%) $10.98
USD/GBP
(-0.05%) $0.797
USD/RUB
(0.00%) $91.13

Realaus laiko atnaujinimai Coloplast A/S [CBHD.DE]

Birža: XETRA Pramonė: Health Care Equipment & Services
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-07)

Expected move: +/- 0.00%

Atnaujinta2 geg. 2024 @ 18:35

-0.84% 112.60

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 18:35):

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature...

Stats
Šios dienos apimtis 242.00
Vidutinė apimtis 405.00
Rinkos kapitalizacija 25.07B
EPS €0 ( 2023-09-30 )
Kita pelno data ( €0 ) 2024-05-07
Last Dividend €5.00 ( 2023-05-15 )
Next Dividend €0 ( N/A )
P/E 37.66
ATR14 €0 (0.00%)

Coloplast A/S Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Coloplast A/S Finansinės ataskaitos

Annual 2023
Pajamos: €24.50B
Bruto pelnas: €16.33B (66.64 %)
EPS: €22.21
FY 2023
Pajamos: €24.50B
Bruto pelnas: €16.33B (66.64 %)
EPS: €22.21
FY 2022
Pajamos: €22.58B
Bruto pelnas: €15.53B (68.78 %)
EPS: €22.14
FY 2021
Pajamos: €19.43B
Bruto pelnas: €13.31B (68.53 %)
EPS: €22.70

Financial Reports:

No articles found.

Coloplast A/S Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
€0
(N/A)
€15.00
(N/A)
€0
(N/A)
€5.00
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)
€0
(N/A)

Coloplast A/S Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 8.24 - good (82.42%) | Divividend Growth Potential Score: 4.74 - Stable (5.25%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend €1.800 2007-12-19
Last Dividend €5.00 2023-05-15
Next Dividend €0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 27 --
Total Paid Out €171.20 --
Avg. Dividend % Per Year 0.00% --
Score 3.22 --
Div. Sustainability Score 8.24
Div.Growth Potential Score 4.74
Div. Directional Score 6.49 --
Next Divdend (Est)
(2024-07-12)
€4.49 Estimate 3.50 %
Dividend Stability
0.28 Very Poor
Dividend Score
3.22
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for XETRA

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
NWO.DE Ex Dividend Knight 2023-05-25 Annually 0 0.00%
ADS.F Ex Dividend Junior 2023-05-12 Annually 0 0.00%
GOB.DE Ex Dividend Knight 2023-06-12 Sporadic 0 0.00%
RAA.DE Ex Dividend Knight 2023-05-11 Annually 0 0.00%
BLQA.DE Ex Dividend Knight 2023-09-07 Quarterly 0 0.00%
INN1.DE Ex Dividend Junior 2023-08-07 Semi-Annually 0 0.00%
SYT.DE Ex Dividend Junior 2023-05-05 Annually 0 0.00%
CTO.DE Ex Dividend Knight 2023-08-24 Quarterly 0 0.00%
LUS1.DE Ex Dividend Junior 2023-06-23 Annually 0 0.00%
1U1.DE Ex Dividend Junior 2023-05-17 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1941.5006.119.17[0 - 0.5]
returnOnAssetsTTM0.1001.2006.667.99[0 - 0.3]
returnOnEquityTTM0.4291.5006.359.52[0.1 - 1]
payoutRatioTTM1.175-1.00010.00-10.00[0 - 1]
currentRatioTTM0.5320.800-2.34-1.871[1 - 3]
quickRatioTTM0.2810.800-3.06-2.44[0.8 - 2.5]
cashRatioTTM0.04841.500-0.842-1.263[0.2 - 2]
debtRatioTTM0.445-1.5002.58-3.87[0 - 0.6]
interestCoverageTTM10.721.0007.147.14[3 - 30]
operatingCashFlowPerShareTTM27.492.000.8361.672[0 - 30]
freeCashFlowPerShareTTM21.812.0010.0010.00[0 - 20]
debtEquityRatioTTM1.430-1.5004.28-6.42[0 - 2.5]
grossProfitMarginTTM0.6661.0002.232.23[0.2 - 0.8]
operatingProfitMarginTTM0.2751.0006.496.49[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2781.0009.579.57[0.2 - 2]
assetTurnoverTTM0.5150.8009.907.92[0.5 - 2]
Total Score8.24

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM38.011.0006.260[1 - 100]
returnOnEquityTTM0.4292.507.659.52[0.1 - 1.5]
freeCashFlowPerShareTTM21.812.002.7310.00[0 - 30]
dividendYielPercentageTTM2.481.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM27.492.000.8361.672[0 - 30]
payoutRatioTTM1.1751.50010.00-10.00[0 - 1]
pegRatioTTM0.2471.500-1.6840[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2401.0006.500[0.1 - 0.5]
Total Score4.74

Coloplast A/S

Coloplast A/S develops, manufactures, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.

Apie Signalai gyvai

Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.

Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.